Ursolic acid derivatives improved clinical signs of experimental autoimmune encephalomyelitis by modulating central nervous system inflammation
Authors:
- Elaine Carlos ScherrerESElaine Carlos Scherrer
- Ydia Mariele ValadaresYVYdia Mariele Valadares
- Igor Gabriel Machado SoaresISIgor Gabriel Machado Soares
- Alessandra Paula CarliACAlessandra Paula Carli
- Fernando Sá SilvaFSFernando Sá Silva
- Jeferson Gomes SilvaJSJeferson Gomes Silva
- Daniel Gomes AlvarengaDADaniel Gomes Alvarenga
- Alessa Sin Singer BrugioloABAlessa Sin Singer Brugiolo
- Rodrigo Moreira VerlyRodrigo Moreira Verly
- Maiara Rodrigues SalvadorMSMaiara Rodrigues Salvador
- Angelo Marcio Leite DenadaiADAngelo Marcio Leite Denadai
- 1 April 2025
- journal article
- research article
- Published by Springer Nature in Metabolic Brain Disease
- Vol. 40 (4) , 1-11
Abstract
The immunopathogenesis of multiple sclerosis (MS) involves the activation of T lymphocytes, leading to progressive axonal loss and brain atrophy. Ursolic acid (AU) has been widely used as an herbal medicine, with the ability to inhibit the production and secretion of cytokines and may influence the differentiation of CD4 + helper cells. In this study, we aimed to investigate the immunomodulatory effects of ursolic acid derivatives (methyl 3β-hydroxyurs-12-en-28-oate (AUD1) and methyl 3β-acetoxyurs-12-en-28-oate (AUD2)) in a model of experimental autoimmune encephalomyelitis (EAE). EAE was induced by subcutaneous immunization of myelin oligodendrocyte glycoprotein peptide (MOG35−55) in C57BL/6 mice. On the 15th day post-induction (dpi), the mice were treated with AU, AUD1, or AUD2 (50 mg/kg intraperitoneally per day) for six days. Clinical signs were monitored until 21 dpi, and parameters were assessed in the spinal cord, lymph nodes, and brain at 21 dpi. The results showed that both derivatives similarly attenuated the clinical signs of EAE and reduced inflammation and demyelination in the spinal cord. In addition, they reduced the number of pro-inflammatory cells in the brain, the level of IL-1β, TNF, and IFN-γ in the spinal cord, and, in the periphery, promoted the regulation of pro-inflammatory cells. In conclusion, regulating cells in the periphery and reducing the number of pro-inflammatory cells in the CNS, with AUD1 and AUD2, culminated in the efficacy of the clinical parameters presented in EAE, suggesting a therapeutic potential for treating MS.Keywords
Funding Information
- Conselho Nacional de Desenvolvimento Científico e Tecnológico (431816/2018-2; CNPQ-NANO 550321/2012-8, 308278/2020-8, and 437418/2018-9, 431816/2018-2; CNPQ-NANO 550321/2012-8, 308278/2020-8, and 437418/2018-9, 431816/2018-2; CNPQ-NANO 550321/2012-8, 308278/2020-8, and 437418/2018-9)
- Financiadora de Estudos e Projetos (0633/13)
- Fundação de Amparo à Pesquisa do Estado de Minas Gerais (APQ 02052-21; APQ 02423-18, APQ 02506-22, APQ 00607-22, APQ 04955-23, and APQ 03152-18, APQ 02052-21; APQ 02423-18, APQ 02506-22, APQ 00607-22, APQ 04955-23, and APQ 03152-18)
This publication has 31 references indexed in Scilit:
- Ursolic acid (UA): A metabolite with promising therapeutic potentialLife Sciences, 2016
- Ursolic acid ameliorates autoimmune arthritis via suppression of Th17 and B cell differentiationActa Pharmacologica Sinica, 2014
- Stimulated PBMC-produced IFN- and TNF- are associated with altered relapse risk in multiple sclerosis: results from a prospective cohort studyJournal of Neurology, Neurosurgery & Psychiatry, 2014
- Interleukin-10 plays a crucial role in suppression of experimental autoimmune encephalomyelitis by Bowman–Birk inhibitorJournal of Neuroimmunology, 2012
- Potent Anti-Inflammatory Activity of Ursolic Acid, a Triterpenoid Antioxidant, Is Mediated through Suppression of NF-κB, AP-1 and NF-ATPLOS ONE, 2012
- Experimental autoimmune encephalomyelitis (EAE) as a model for multiple sclerosis (MS)British Journal of Pharmacology, 2011
- Ursolic Acid Suppresses Interleukin-17 (IL-17) Production by Selectively Antagonizing the Function of RORγt ProteinJournal of Biological Chemistry, 2011
- Genistein down-modulates pro-inflammatory cytokines and reverses clinical signs of experimental autoimmune encephalomyelitisInternational Immunopharmacology, 2008
- Amelioration of adjuvant-induced arthritis by ursolic acid through altered Th1/Th2 cytokine productionPharmacological Research, 2006
- A Pathogenic Role for Myelin-Specific Cd8+ T Cells in a Model for Multiple SclerosisJournal of Experimental Medicine, 2001